[Federal Register Volume 71, Number 157 (Tuesday, August 15, 2006)]
[Notices]
[Page 46895]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 06-6906]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Meeting of the Uniform Formulary Beneficiary Advisory Panel

AGENCY: Department of Defense, Assistant Secretary of Defense (Health 
Affairs).

ACTION: Notice of Meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a meeting of the Uniform Formulary 
Beneficiary Advisory Panel. The panel will review and comment on 
recommendations made to the Director, TRICARE Management Activity, by 
the Pharmacy and Therapeutics Committee regarding the Uniform 
Formulary. The meeting will be open to the public. Seating is limited 
and will be provided only to the first 220 people signing in. All 
persons must sign in legibly. Notice of this meeting is required under 
the Federal Advisory Committee Act.

DATES: Thursday, September 21, 2006, from 8 a.m. to 4 p.m.

ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue, NW., 
Washington, DC 2004.

FOR FURTHER INFORMATION CONTACT: Mr. Rich Martel, TRICARE Management 
Activity, Pharmaceutical Operations Directorate, Beneficiary Advisory 
Panel, Suite 810, 5111 Leesburg Pike, Falls Church, VA 22041, telephone 
703-681-2890, ext. 6718, fax 703-681-1940, or e-mail at 
<a href="/cdn-cgi/l/email-protection#4d2f2c3d3f283c38283e393e0d39202c63223e2963202421"><span class="__cf_email__" data-cfemail="99fbf8e9ebfce8ecfceaedead9edf4f8b7f6eafdb7f4f0f5">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: The Uniform Formulary Beneficiary Advisory 
Panel will only review and comment on the development of the Uniform 
Formulary as reflected in the recommendations DOD Pharmacy and 
Therapeutics (P&T) Committee coming out of that body's meeting in 
August 2006. The P&T Committee information and subject matter 
concerning drug classes reviewed for that meeting are available at 
http://www.pec.ha.osd.mil. Any private citizen is permitted to file a 
written statement with the advisory panel. Statements must be submitted 
electronically to <a href="/cdn-cgi/l/email-protection#b3d1d2c3c1d6c2c6d6c0c7c0f3c7ded29ddcc0d79ddedadf"><span class="__cf_email__" data-cfemail="c7a5a6b7b5a2b6b2a2b4b3b487b3aaa6e9a8b4a3e9aaaeab">[email protected]</span></a> no later than September 14, 
2006. Any private citizen is permitted to speak at the Beneficiary 
Advisory Panel meeting, time permitting. One hour will be reserved for 
public comments, and speaking times will be assigned only to the first 
twelve citizens to sign up at the meeting, on a first-come, first-
served basis. The amount of time allocated to a speaker will not exceed 
five minutes.

    Dated: August 8, 2006.
C.R. Choate,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 06-6906 Filed 8-14-06; 8:45 am]
BILLING CODE 5001-06-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>